In Brief Case Comprehensive Cancer Center receives $10.4 million NCI grant for glioblastoma research September 25, 2020Vol.46 No.36
In Brief Moffitt Cancer Center study educates oncologists on LGBTQ+ health concerns September 25, 2020Vol.46 No.36
Conversation with The Cancer Letter Vincent Vinciguerra receives NCORP 2020 Harry Hynes Award September 25, 2020Vol.46 No.36By Paul Goldberg
NCI will form an ad hoc committee to review screening trialsThe future of ECOG-ACRIN's slowly-accruing TMIST is in question September 11, 2020Vol.46 No.34By Paul Goldberg
Drugs & Targets Pralsetinib receives FDA approval for lung cancer with RET gene fusions September 11, 2020Vol.46 No.34
Drugs & Targets Oncomine Dx Target Test receives FDA approval as first NGS-based companion diagnostic for RET fusion + NSCLC September 11, 2020Vol.46 No.34
Drugs & Targets FDA issues alert about efficacy and potential safety concerns with atezolizumab in combination with paclitaxel for treatment of breast cancer September 11, 2020Vol.46 No.34
Drugs & Targets Oncocyte receives final pricing decision for DetermaRx Molecular Test for lung cancer from CMS September 11, 2020Vol.46 No.34
Drugs & Targets MD Anderson, Xencor collaborate on investigational XmAb drug candidates September 11, 2020Vol.46 No.34
